(Q43753558)

26 November 2017

title

Treatment strategy and long-term results in pediatric patients treated in two consecutive AML-GATLA trials (English)

1 reference

26 November 2017

H Armendariz

1

1 reference

26 November 2017

M A Fernandez Barbieri

2

1 reference

26 November 2017

D Freigeiro

3

1 reference

26 November 2017

F Lastiri

4

1 reference

26 November 2017

M S Felice

5

1 reference

26 November 2017

E Dibar

6

1 reference

26 November 2017

language of work or name

1 reference

1 December 2005

1 reference

26 November 2017

1 reference

26 November 2017

volume

19

1 reference

26 November 2017

issue

12

1 reference

26 November 2017

page(s)

2139-2142

1 reference

Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. AML-BFM Study Group

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403854

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403854

Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403854

Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403854

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403854

1 reference

Dimensions Publication ID

26 November 2017

1031232975

0 references

1 reference